Celgene IBD Pipeline In Question As Mongersen Crohn’s Disease Trial Ends

Crohn's disease
Celgene Stopped A Phase III Trial For Mongersen In Crohn's Disease • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Clinical Trials

More from R&D